Milnerowicz, S.; Maszewska, J.; Skowera, P.; Stelmach, M.; Lejman, M.
AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens. Int. J. Mol. Sci. 2023, 24, 15849.
https://doi.org/10.3390/ijms242115849
AMA Style
Milnerowicz S, Maszewska J, Skowera P, Stelmach M, Lejman M.
AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens. International Journal of Molecular Sciences. 2023; 24(21):15849.
https://doi.org/10.3390/ijms242115849
Chicago/Turabian Style
Milnerowicz, Szymon, Julia Maszewska, Paulina Skowera, Magdalena Stelmach, and Monika Lejman.
2023. "AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens" International Journal of Molecular Sciences 24, no. 21: 15849.
https://doi.org/10.3390/ijms242115849
APA Style
Milnerowicz, S., Maszewska, J., Skowera, P., Stelmach, M., & Lejman, M.
(2023). AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens. International Journal of Molecular Sciences, 24(21), 15849.
https://doi.org/10.3390/ijms242115849